Table 2.
Case fatality and other characteristics of the studies of S. aureus ventilator-associated pneumonia
| Study site, year published | Number of patients | Years of study | Mean age (years) | Male gender (%) |
Length of hospital stay (days) | Total charges, median | Crude in-hospital mortality | Infection related mortality | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSA | MSSA | MRSA | MSSA | MRSA | MSSA | MRSA | MSSA | MRSA | MSSA | MRSA | MSSA | |||
| USA 2010 [33] | 142 | 2005-2008 | 66 | 63 | 46% | 60% | 14 | 14 | 70,028$ | 71,186 $ | 29% | 20% | ||
| Germany 2010* | 2,411 | 2005-2009 | 67 | 60 | 67% | 65% | *27% | *14% | ||||||
| France 2008 [67] | 42 | 2004 | 57 | #59 | 38% | #57% | 41 | #43 | 8,915€ | #8,398€ | 38% | #29% | ||
| USA 2006 [31] | 154 | 2002-2003 | 74 | 67 | 56% | 53% | 20 | 15 | 40,734$ | 36,523$ | 29% | 36% | ||
| USA 2005 [21] | 60 | 1999-2004 | 58.4 | 55.2 | ^16 | ^16 | 55% | 56% | 41% | 39% | ||||
| Germany 2005 [68] | 1,851 | 1997-2002 | *17% | *7% | ||||||||||
| 134 | 1997-2004 | 68 | 63 | 71% | 72% | 59% | 40% | |||||||
| France 2004 [28] | 171 | 64 | 58 | 45% | 62% | °30 | °27 | 49% | 29% | |||||
| Spain 1998 [70] | 139 | 1990-1994 | 55 | 43 | 78% | 72% | 56% | 38% | ||||||
| Netherlands 1998 [28] | 256 | 33% | 29% | |||||||||||
| Spain 1995 [27] | 86 | 1990-1995 | 69 | 57 | 66% | 57% | 56% | 41% | ||||||
| Spain 1994 [25] | 49 | 1991-1993 | 60 | 44 | 81% | 60% | 75% | 12% | ||||||
Bold if statistically significant *ICU mortality, # control group i.e. matched patients not only patients with MSSA pneumonia, ^infection related length of stay, °ICU stay after VAP onset * Data from the Krankenhaus Infection Surveilance System (KISS)